Lumen Biomedical, Inc.
USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Lumen ranks #48,468 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.
- #48,468
- of 49,997 US assignees by volume
- 8th percentile
- by Innovation Score (21.1/100)
- 14.6
- avg claims per patent
- -33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R48468 · US Corporation #48,468 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #48,468/49,997
- PHOTO-FINISH Lucid Vision Labs
- CPC-NARROW A61B · 3 areas
- INNOV-THIN 21.1/100
- CLAIMS-RICH 14.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Lucid Vision Labs, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Lumen’s 21.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Lumen
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Lumen Biomedical · this assignee 21
Lumen Biomedical · this assignee
21 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Lumen's Innovation Score is 21.1/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Lumen?
Each dot is one of Lumen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lumen’s own 14.6 claims/patent is at or below the 20.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Lumen's grants concentrate
Lumen Biomedical, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Lumen sits between Lucid Vision Labs, Inc. and LumiThera, Inc..
Who files at Lumen's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Lucid Vision Labs
Lucid Vision Labs, Inc.
5 patents
- Ludlum Measuremen…
Ludlum Measurements, Inc.
5 patents
- Ludwig Ehrhardt
Ludwig Ehrhardt GmbH
5 patents
- Lumacyte
Lumacyte, Inc.
5 patents
- Lumen Labs (HK)
Lumen Labs (HK) Limited
5 patents
- Lumex Dmcc
Lumex Dmcc
5 patents
- Lumexis
Lumexis Corporation
5 patents
- Lumithera
LumiThera, Inc.
5 patents
- Lumen Biomedical ◀
Lumen Biomedical, Inc.
5 patents
What this shows Lumen holds 5 patents at rank #48,488, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Lumen
By rank, the assignees closest to #48,488 in granted patent volume.
- Lucid Vision Labs, Inc. #48,484 · 5 patents
- Ludlum Measurements, Inc. #48,485 · 5 patents
- Ludwig Ehrhardt GmbH #48,486 · 5 patents
- Lumacyte, Inc. #48,487 · 5 patents
- Lumen Labs (HK) Limited #48,489 · 5 patents
- Lumex Dmcc #48,490 · 5 patents
- Lumexis Corporation #48,491 · 5 patents
- LumiThera, Inc. #48,492 · 5 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Lumen's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Lumen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
21 8th percentile higher than 8% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 20.0% |
| 2017 | 1 | 20.0% |
| 2018 | 1 | 20.0% |
| 2020 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
Which technologies does Lumen Biomedical, Inc. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Lumen Biomedical, Inc.'s patent record in context - here's where to go next.
- Lumen Biomedical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #48,468 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Lumen Biomedical, Inc. against Lucid Vision Labs, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 21.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.